TASI 8313 · Insurance · RASAN
Statement of Changes in Equity
9M / Q3 2026Equity movements
| Movement | Total shareholders’ equitySAR |
|---|---|
| Balance at 1 January 2025 (Audited) | 414,895,635 |
| Net income for the period (Restated – refer to Note 20) | 146,922,700 |
| Other comprehensive income / (loss) | (777,145) |
| Total comprehensive income / (loss) (restated) | 146,145,555 |
| Capital increase (Note 11) | - |
| Shares held for employee share purchase plan (Note 12) | - |
| Share-based payments (Note 12, Restated – refer to Note 20) | 46,512,780 |
| Shares vested during the period (Note 12, Restated – refer to Note 20) | - |
| Income tax reimbursed by non-Saudi shareholder (Note 6) | 1,852,625 |
| Balance at 30 September 2025 (unaudited) | 609,406,595 |
| Balance at 1 January 2026 (Audited) | 705,438,900 |
| Restatements and reclassifications (Note 20) | 13,261,387 |
| Balance at 1 January 2026 (Restated - refer to Note 20) | 718,700,287 |
| Net income for the period | 284,068,215 |
| Other comprehensive income / (loss) | (888,116) |
| Total comprehensive income / (loss) | 283,180,099 |
| Share-based payments (Note 12) | 81,472,340 |
| Shares vested during the period (Note 12) | - |
| Income tax reimbursed by non-Saudi shareholder (Note 6) | 1,126,265 |
| Balance at 30 September 2026 (unaudited) | 1,084,478,991 |
Note 20 explains which 2025 figures were restated or reclassified and reconciles the changes to the figures originally published. The comparative columns in this filing use the revised figures. 2025 comparative restatements · Page 23 ↗